Skip to main content

Table 2 Healthcare Costs and Utilities

From: Quality of life and cost consequence of delays in endovascular treatment for acute ischemic stroke in China

 

Costs/Utility

Lower Boundary

Upper Boundary

Reference

Acute 90-day Healthcare Costs; by 90-day mRS

 mRS 0–2

¥11,314

¥11,147

¥11,483

CNSR [17]

 mRS 3–5

¥15,448

¥15,109

¥15,792

 mRS 6

¥12,513

¥11,499

¥13,594

Long-Term Annual Healthcare Costs; by 90-day mRS

 

 mRS 0–2

¥8310

¥8052

¥8573

CNSR

 mRS 3–5

¥12,771

¥11,499

¥13,594

Additional Cost of IVT

¥68,436

¥58,864

¥79,115

EAST [17]

Additional Cost of EVT

¥12,579

¥11,877

¥13,310

CNSR, TIMS-CHINA [17]

Cost of Recurrent Stroke

¥15,448

¥15,109

¥15,792

EAST [17]

Utilities; by 90-day mRS

 mRS 0

0.92

0.88

0.96

Ali et al. [18]

 mRS 1

0.84

0.81

0.87

 mRS 2

0.74

0.70

0.78

 mRS 3

0.58

0.53

0.63

 mRS 4

0.37

0.32

0.42

 mRS 5

0.15

0.11

0.19

  1. All costs are in Chinese Yuan. EVT endovascular treatment, IVT intravenous thrombolysis, mRS modified Rankin Scale